-->
The urinary excretion of viable podocytes, or glomerular epithelial cells, is an important marker for preeclampsia, according to a report in the April issue of the American Journal of Obstetrics and Gynecology.
Vesna D. Garovic, MD, of the Mayo Clinic in Rochester, Minn., and colleagues measured urinary podocyte excretion in 44 patients with preeclampsia and 23 normotensive control patients. They also measured blood levels of angiogenic factors that play a role in the pathogenesis of preeclampsia: s-Flt-1, PlGF, and endoglin.
The researchers identified urinary podocyte excretion in all 44 preeclampsia patients. They also found that podocyturia had a greater positive predictive value than any of the angiogenic factors for the diagnosis of preeclampsia.
Garovic VD, Wagner SJ, Turner ST, et al. Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol. 2007;196: 320.e1-.e7.
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
Unraveling preeclampsia: Insights into heterogeneity and intravascular inflammation
April 22nd 2024A recent study delved into the intricate clusters of term preeclampsia, shedding light on its diverse manifestations and the pivotal role of intravascular inflammation, paving the way for improved classification and management strategies.
Read More